Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D S Chi

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
Gynecologic Oncology|May 23, 2006
What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?D S Chi, E L Eisenhauer, J Lang, et al.
Gynecologic Oncology|December 27, 2008
Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapyO Zivanovic, M M Leitao, K J Park, et al.
Gynecologic Oncology|May 5, 2012
Anterior pelvic exenteration with total vaginectomy for recurrent or persistent genitourinary malignancies: review of surgical technique, complications, and outcomeV Andikyan, F Khoury-Collado, S R Gerst, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 7, 2007
Extended pelvic resections for recurrent uterine and cervical cancer: out-of-the-box surgeryA Caceres, S M Mourton, B H Bochner, et al.
Gynecologic Oncology|January 31, 2012
Extended pelvic resections for recurrent or persistent uterine and cervical malignancies: an update on out of the box surgeryV Andikyan, F Khoury-Collado, Y Sonoda, et al.
Gynecologic Oncology|April 4, 2017
Trends and factors associated with radical cytoreductive surgery in the United States: A case for centralized careA K Sinno, X Li, R E Thompson, et al.
Gynecologic Oncology|December 22, 2009
A nomogram for predicting overall survival of women with endometrial cancer following primary therapy: toward improving individualized cancer careN R Abu-Rustum, Q Zhou, J D Gomez, et al.
Gynecologic Oncology|May 17, 2011
Malignant melanoma of the vulva: an extension of cutaneous melanoma?K M Moxley, A N Fader, P G Rose, et al.
Gynecologic Oncology|May 17, 2011
Sentinel lymph node mapping for endometrial cancer improves the detection of metastatic disease to regional lymph nodesF Khoury-Collado, M P Murray, M L Hensley, et al.
Gynecologic Oncology|May 16, 2013
Optimal (≤1 cm) but visible residual disease: is extensive debulking warranted?J N Barlin, K C Long, E J Tanner, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Gynecologic Oncology|May 23, 2006
What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?D S Chi, E L Eisenhauer, J Lang, et al.
Gynecologic Oncology|December 27, 2008
Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapyO Zivanovic, M M Leitao, K J Park, et al.
Gynecologic Oncology|May 5, 2012
Anterior pelvic exenteration with total vaginectomy for recurrent or persistent genitourinary malignancies: review of surgical technique, complications, and outcomeV Andikyan, F Khoury-Collado, S R Gerst, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 7, 2007
Extended pelvic resections for recurrent uterine and cervical cancer: out-of-the-box surgeryA Caceres, S M Mourton, B H Bochner, et al.
Gynecologic Oncology|January 31, 2012
Extended pelvic resections for recurrent or persistent uterine and cervical malignancies: an update on out of the box surgeryV Andikyan, F Khoury-Collado, Y Sonoda, et al.
Gynecologic Oncology|April 4, 2017
Trends and factors associated with radical cytoreductive surgery in the United States: A case for centralized careA K Sinno, X Li, R E Thompson, et al.
Gynecologic Oncology|December 22, 2009
A nomogram for predicting overall survival of women with endometrial cancer following primary therapy: toward improving individualized cancer careN R Abu-Rustum, Q Zhou, J D Gomez, et al.
Gynecologic Oncology|May 17, 2011
Malignant melanoma of the vulva: an extension of cutaneous melanoma?K M Moxley, A N Fader, P G Rose, et al.
Gynecologic Oncology|May 17, 2011
Sentinel lymph node mapping for endometrial cancer improves the detection of metastatic disease to regional lymph nodesF Khoury-Collado, M P Murray, M L Hensley, et al.
Gynecologic Oncology|May 16, 2013
Optimal (≤1 cm) but visible residual disease: is extensive debulking warranted?J N Barlin, K C Long, E J Tanner, et al.
Pageof 11